Cargando…
Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal
BACKGROUND: Metformin (Met) is a widely available diabetic drug and shows suppressed effects on renal cell carcinoma (RCC) metabolism and proliferation. Laboratory studies in RCC suggested that metformin has remarkable antitumor activities and seems to be a potential antitumor drug. But the facts th...
Autores principales: | Wei, Muyun, Mao, Shaowei, Lu, Guoliang, Li, Liang, Lan, Xiaopeng, Huang, Zhongxian, Chen, Yougen, Zhao, Miaoqing, Zhao, Yueran, Xia, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902941/ https://www.ncbi.nlm.nih.gov/pubmed/29665787 http://dx.doi.org/10.1186/s12885-018-4344-3 |
Ejemplares similares
-
FKBP51 promotes invasion and migration by increasing the autophagic degradation of TIMP3 in clear cell renal cell carcinoma
por: Mao, Shaowei, et al.
Publicado: (2021) -
Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells
por: Xia, Qinghua, et al.
Publicado: (2016) -
TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells
por: Zhang, Zewei, et al.
Publicado: (2017) -
Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal
por: Yin, Xiteng, et al.
Publicado: (2018) -
Metformin induces protein acetylation in cancer cells
por: Vancura, Ales, et al.
Publicado: (2017)